Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giral

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)M Merlos, M Giral, D Balsa, et al.
Journal of Medicinal Chemistry|August 19, 1994
[(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamineE Carceller, M Merlos, M Giral, et al.
Transplantation Proceedings|February 1, 1989
Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoringJ N Trochu, M Denis, J L Auget, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2000
Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantationD Cantarovich, M Giral-Classe, M Hourmant, et al.
The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.
Kidney International|September 12, 1998
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneysM Giral-Classe, M Hourmant, D Cantarovich, et al.
Transplantation|March 1, 1989
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1994
[Pancreatic transplantation: six years' experience CHU of Nantes]D Cantarovich, G Karam, M Hourmant, et al.
Tissue Antigens|August 1, 1997
Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA lociD Chevrier, M Giral, R Perrichot, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)M Merlos, M Giral, D Balsa, et al.
Journal of Medicinal Chemistry|August 19, 1994
[(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamineE Carceller, M Merlos, M Giral, et al.
Transplantation Proceedings|February 1, 1989
Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1992
Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoringJ N Trochu, M Denis, J L Auget, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2000
Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantationD Cantarovich, M Giral-Classe, M Hourmant, et al.
The New England Journal of Medicine|April 26, 1990
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allograftsJ P Soulillou, D Cantarovich, B Le Mauff, et al.
Kidney International|September 12, 1998
Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneysM Giral-Classe, M Hourmant, D Cantarovich, et al.
Transplantation|March 1, 1989
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot studyD Cantarovich, B Le Mauff, M Hourmant, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1994
[Pancreatic transplantation: six years' experience CHU of Nantes]D Cantarovich, G Karam, M Hourmant, et al.
Tissue Antigens|August 1, 1997
Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA lociD Chevrier, M Giral, R Perrichot, et al.
Pageof 8